Cambridge Trust’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-150
Closed -$3K 769
2022
Q4
$3K Hold
150
﹤0.01% 741
2022
Q3
$2K Sell
150
-600
-80% -$13.5K ﹤0.01% 775
2022
Q2
$19K Hold
750
﹤0.01% 610
2022
Q1
$27K Hold
750
﹤0.01% 626
2021
Q4
$57K Buy
+750
New +$66.1K ﹤0.01% 503

Other funds holding CRNC

Cambridge Trust's CRNC Position: Q1 2023 in Review

Cambridge Trust sold out of Cerence (CRNC) in Q1 2023, closing a stake of 150 shares — an estimated $3K sold.

Cambridge Trust first reported a position in CRNC in Q4 2021 and held it in 5 quarters. The position peaked at $57K in Q4 2021. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.

  • Cambridge Trust reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
  • Cambridge Trust sold 150 Cerence shares in Q1 2023, an estimated $3K.
  • Cambridge Trust first reported a position in Cerence in Q4 2021 and held it in 5 quarters.
  • Cambridge Trust's Cerence position peaked at $57K in Q4 2021.
  • 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.

Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.